Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05824975
What this trial is testing

Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more
GI Innovation, Inc. 358
Early research (Phase 1)Active Not RecruitingNCT03821935
What this trial is testing

Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 364
Large-scale testing (Phase 3)Study completedNCT00716976
What this trial is testing

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Who this might be right for
Brain TumorCentral Nervous System TumorChildhood Germ Cell Tumor+6 more
Children's Oncology Group 131
Not applicableActive Not RecruitingNCT01047735
What this trial is testing

The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusObesity
University of Pittsburgh 69
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT06084884
What this trial is testing

A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
AstraZeneca 94
Testing effectiveness (Phase 2)Looking for participantsNCT05150691
What this trial is testing

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Who this might be right for
HER2-positive Advanced Solid Tumor
DualityBio Inc. 796
Early research (Phase 1)Study completedNCT02572687
What this trial is testing

Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies

Who this might be right for
Gastric CancerGastroesophageal Junction AdenocarcinomaNon-Small Cell Lung Cancer+1 more
Eli Lilly and Company 85
Large-scale testing (Phase 3)Study completedNCT05665348
What this trial is testing

Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy

Who this might be right for
HCC - Hepatocellular CarcinomaMetastatic CancerMetastatic Tumor
Federation Francophone de Cancerologie Digestive 229
Not applicableLooking for participantsNCT05053555
What this trial is testing

High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies

Who this might be right for
Liver Malignant TumorsCholangiocarcinoma MetastaticPancreatic Cancer+1 more
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)UnknownNCT02528526
What this trial is testing

Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm

Who this might be right for
Pancreatic NeoplasmsHepatocellular CancerCholangiocarcinoma+1 more
University of Zurich 69
Not applicableStudy completedNCT02032368
What this trial is testing

Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence

Who this might be right for
Circulating Tumor Cell;Hepatocellular Carcinoma
Guangdong Provincial People's Hospital 57
Early research (Phase 1)Study completedNCT04313868
What this trial is testing

GEN2 Directed Cancer Immunotherapy Trial

Who this might be right for
Hepatocellular CarcinomaMetastatic Cancer
GenVivo, Inc. 61
Not applicableNo Longer AvailableNCT00701168
What this trial is testing

Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer

Who this might be right for
Carcinoma, HepatocellularNeoplasm Metastasis
Leo W. Jenkins Cancer Center
Not applicableUnknownNCT01180088
What this trial is testing

Effectiveness of Routine Application Of Anterior Approach During Right Hepatectomy

Who this might be right for
Liver Neoplasm
Azienda Ospedaliera Ordine Mauriziano di Torino 60
Testing effectiveness (Phase 2)Study completedNCT01253161
What this trial is testing

Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)

Who this might be right for
Neuroendocrine TumorsCarcinoid Tumors
H. Lee Moffitt Cancer Center and Research Institute 29
Not applicableLooking for participantsNCT07377487
What this trial is testing

TheraSphere Japan Pre-Market Study

Who this might be right for
Liver Neoplasms
Boston Scientific Corporation 51
Not applicableStudy completedNCT00681499
What this trial is testing

Quality of Life After Liver Resection

Who this might be right for
Liver DiseasesLiver Neoplasms
University of Bern 198
Testing effectiveness (Phase 2)Looking for participantsNCT05039632
What this trial is testing

Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Neoplasm in the Lung+1 more
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT02683538
What this trial is testing

Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies

Who this might be right for
Hepatocellular CarcinomaMetastasisCholangiocarcinoma
Seoul National University Hospital 196
Next Page